Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mechanistic Focus in Research Within controlled laboratory settings, BPC-157/TB-500 is commonly studied in relation to peptide-mediated signalling networks and cellular regulatory mechanisms
Pregnant or breastfeeding women safety unknown Cancer patients or those with tumor history due to VEGF promotion, angiogenesis could theoretically support tumor growth Autoimmune disorders while BPC-157 is generally anti-inflammatory, immune modulation can vary by individual Angiogenic peptides may pose theoretical risks in neoplastic conditions by promoting blood vessel formation
Next 5-10 years should produce higher-quality human data replacing current reliance on animal studies and anecdotal reports
Keep the blend as the anchor
Mirror progress is still subtle
US$ 24.77
US$ 26.91
US$ 28.78
